aod9604 clinical trial 2024 AOD 9604: Peptide Claims vs Reality AOD 9604 is marketed as a fat-metabolism peptide derived from a growth hormone fragment, often positioned as “HGH-like” without HGH's side effects. The clinical question AOD-9604 Clinical Trial Results &
Description
Eventually, a plateau occurs
A typical loading dose is 1,000 mcg (1 mg) administered intramuscularly several times per week (such as every other day or 3 times per week) for a couple of weeks
Isoniazid, penicillamine, and some seizure drugs (like phenytoin) may lower vitamin B6 levels, so your provider may adjust doses
doi: 10.1210/jcem.87.5.8628
I feel amazing
You are responsible for applicable duties, taxes, import charges, and payment-provider fees
